These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 20496567

  • 21. Combined chemotherapy trials with regimens containing ofloxacin and rifampicin for multibacillary leprosy patients.
    Sampoonachot P, Bundit C, Kuhacharoen N, Peerapakorn S, Kampirapap K, Poomlek A, Bampenyu S, Tiasiri S, Rungruang S, Surasondhi S, Supanwanit S, Wiriyawipart S.
    J Med Assoc Thai; 1996 Apr; 79(4):210-7. PubMed ID: 8708505
    [Abstract] [Full Text] [Related]

  • 22. Daily multidrug therapy for leprosy; results of a fourteen-year experience.
    de Carsalade GY, Wallach D, Spindler E, Pennec J, Cottenot F, Flageul B.
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):37-44. PubMed ID: 9207752
    [Abstract] [Full Text] [Related]

  • 23. Ofloxacin containing combined drug regimens in the treatment of multibacillary leprosy.
    Sampoonachot P, Bundit C, Kuhacharoen N, Peerapakorn S, Kampirapap K, Poomlek A, Bampenyu S, Tiasiri S, Rungruang S, Surasondhi S, Supanwanit S, Wiriyawipart S.
    Southeast Asian J Trop Med Public Health; 1997 Dec; 28(4):803-10. PubMed ID: 9656405
    [Abstract] [Full Text] [Related]

  • 24. Combined 12-month WHO/MDT MB regimen and Mycobacterium w. vaccine in multibacillary leprosy: a follow-up of 136 patients.
    Kaur I, Dogra S, Kumar B, Radotra BD.
    Int J Lepr Other Mycobact Dis; 2002 Sep; 70(3):174-81. PubMed ID: 12483965
    [Abstract] [Full Text] [Related]

  • 25. Multidrug therapy in leprosy can prevent relapse--a retrospective study.
    Biswas S, Mondal KK.
    Indian J Lepr; 2002 Sep; 74(4):313-8. PubMed ID: 12624979
    [Abstract] [Full Text] [Related]

  • 26. Efficacy of single dose multidrug therapy for the treatment of single-lesion paucibacillary leprosy. Single-lesion Multicentre Trial Group.
    Indian J Lepr; 1997 Sep; 69(2):121-9. PubMed ID: 9290963
    [Abstract] [Full Text] [Related]

  • 27. New lesions after MDT in PB and MB leprosy: a report of 28 cases.
    Kar HK, Sharma P.
    Indian J Lepr; 2008 Sep; 80(3):247-55. PubMed ID: 19432355
    [Abstract] [Full Text] [Related]

  • 28. World Health Organization (WHO) antibiotic regimen against other regimens for the treatment of leprosy: a systematic review and meta-analysis.
    Lazo-Porras M, Prutsky GJ, Barrionuevo P, Tapia JC, Ugarte-Gil C, Ponce OJ, Acuña-Villaorduña A, Domecq JP, De la Cruz-Luque C, Prokop LJ, Málaga G.
    BMC Infect Dis; 2020 Jan 20; 20(1):62. PubMed ID: 31959113
    [Abstract] [Full Text] [Related]

  • 29. International open trial of uniform multi-drug therapy regimen for 6 months for all types of leprosy patients: rationale, design and preliminary results.
    Kroger A, Pannikar V, Htoon MT, Jamesh A, Katoch K, Krishnamurthy P, Ramalingam K, Jianping S, Jadhav V, Gupte MD, Manickam P.
    Trop Med Int Health; 2008 May 20; 13(5):594-602. PubMed ID: 18346026
    [Abstract] [Full Text] [Related]

  • 30. Fixed duration MDT in paucibacillary leprosy (classical and modified).
    Nadkarni NJ, Grugni A, Kini MS.
    Int J Lepr Other Mycobact Dis; 1993 Mar 20; 61(1):25-8. PubMed ID: 8326177
    [Abstract] [Full Text] [Related]

  • 31. 10-12 years follow-up of highly bacillated BL/LL leprosy patients on combined chemotherapy and immunotherapy.
    Katoch K, Katoch VM, Natrajan M, Sreevatsa, Gupta UD, Sharma VD, Shivanavar CT.
    Vaccine; 2004 Sep 09; 22(27-28):3649-57. PubMed ID: 15315844
    [Abstract] [Full Text] [Related]

  • 32. Relapse rates and a 10-year follow-up of a 6-week quadruple drug regimen for multibacillary leprosy.
    Pattyn S, Grillone S.
    Lepr Rev; 2002 Sep 09; 73(3):245-7. PubMed ID: 12449889
    [Abstract] [Full Text] [Related]

  • 33. Relapses in leprosy patients after release from dapsone monotherapy; experience in the leprosy control program of the all Africa Leprosy and Rehabilitation Training Center (ALERT) in Ethiopia.
    Becx-Bleumink M.
    Int J Lepr Other Mycobact Dis; 1992 Jun 09; 60(2):161-72. PubMed ID: 1522358
    [Abstract] [Full Text] [Related]

  • 34. Four-year follow-up results of a WHO-recommended multiple-drug regimen in paucibacillary leprosy patients in Malawi.
    Boerrigter G, Pönnighaus JM, Fine PE, Wilson RJ.
    Int J Lepr Other Mycobact Dis; 1991 Jun 09; 59(2):255-61. PubMed ID: 2071983
    [Abstract] [Full Text] [Related]

  • 35. Studies on risk of leprosy relapses in China: relapses after treatment with dapsone monotherapy.
    Chen XS, Li WZ, Jiang C, Ye GY.
    Int J Lepr Other Mycobact Dis; 1999 Dec 09; 67(4):371-8. PubMed ID: 10700910
    [Abstract] [Full Text] [Related]

  • 36. Relapse study in smear positive multibacillary (MB) leprosy after 1 year WHO-multi-drug therapy (MDT) in Cebu, Philippines.
    Maghanoy A, Mallari I, Balagon M, Saunderson P.
    Lepr Rev; 2011 Mar 09; 82(1):65-9. PubMed ID: 21644473
    [Abstract] [Full Text] [Related]

  • 37. A comparative clinico-pathological study of single dose ROM in paucibacillary leprosy patients with 1-3 skin lesions.
    Deshmukh AR, Dhurat RS, Jerajani HR.
    Indian J Lepr; 2003 Mar 09; 75(3):209-17. PubMed ID: 15267190
    [Abstract] [Full Text] [Related]

  • 38. Relapses in multibacillary leprosy patients after stopping treatment with rifampin-containing combined regimens. Marchoux Chemotherapy Study Group.
    Jamet P, Ji B.
    Int J Lepr Other Mycobact Dis; 1992 Dec 09; 60(4):525-35. PubMed ID: 1299707
    [Abstract] [Full Text] [Related]

  • 39. Efficacy of single-dose ROM therapy plus low-dose convit vaccine as an adjuvant for treatment of paucibacillary leprosy patients with a single skin lesion.
    Majumder V, Saha B, Hajra SK, Biswas SK, Saha K.
    Int J Lepr Other Mycobact Dis; 2000 Sep 09; 68(3):283-90. PubMed ID: 11221091
    [Abstract] [Full Text] [Related]

  • 40. Effectiveness of MDT in multibacillary leprosy.
    Jesudasan K, Vijayakumaran P, Manimozhi N, Rao PS, Samuel P.
    Int J Lepr Other Mycobact Dis; 1996 Jun 09; 64(2):128-32. PubMed ID: 8690970
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.